Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessReview

Effects of antidepressant treatment on heart rate variability in major depression: A quantitative review

Louis T van Zyl1 email, Takuya Hasegawa1,2 email and Katsutaro Nagata2 email

Department of Psychiatry, Division of Psychosomatic Medicine & Consultation-Liaison Psychiatry, Queen's University at Kingston General Hospital, Connell-4, Suite 2-486, Kingston, ON K7L 2V7, Canada

Hamamatsu University, School of Medicine, Japan, Hamamatsu University School of Medicine, 1-20-1, Handayama, Hamamatsu City, 431-3192, Japan

author email corresponding author email

BioPsychoSocial Medicine 2008, 2:12doi:10.1186/1751-0759-2-12

Published: 30 June 2008

Abstract

Background

The literature measuring effects of antidepressant and electroconvulsive therapy (ECT) for major depression on heart rate variability (HRV) in medically well individuals was reviewed.

Methods

Fourteen studies evaluating HRV were included. Twenty three pre-post or within group comparisons were available. Treatment impact on measures of HRV was pooled over studies. We examined different classes of antidepressants, and for short and long electrocardiogram (ECG) recordings separately.

Results

Tricyclic antidepressants (TCAs) were associated with declines in most measures of HRV and significant increase in heart rate (HR) in studies with short recording intervals. No significant changes were found for longer recording times.

Treatment effects with selective serotonin reuptake inhibitors (SSRIs) were more variable. Short-recording studies revealed a significant decrease in HR and an increase in one HRV measure. In two 24-hour recording studies no significant changes were observed. No relationship between ECT and HRV has been established in the literature. The effects of other drugs are reported.

Limitations

Few studies measure the effects of treatment of depression on HRV. Existing studies have generally used very small samples, employing a variety of measurements and methodologies.

Conclusion

We confirm that TCAs are associated with a large decrease in HRV and increase HR. However, data for SSRIs is not clear. Although the effect of SSRIs on HRV is weaker than for TCAs, evidence shows that SSRIs are associated with a small decrease in HR, and an increase in one measure of HRV. The use of TCAs in depression leads to changes in HRV that are associated with increased risk of mortality.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.